0000899243-18-002039.txt : 20180125
0000899243-18-002039.hdr.sgml : 20180125
20180125200549
ACCESSION NUMBER: 0000899243-18-002039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180123
FILED AS OF DATE: 20180125
DATE AS OF CHANGE: 20180125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Panzara Michael A.
CENTRAL INDEX KEY: 0001679039
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37627
FILM NUMBER: 18549654
MAIL ADDRESS:
STREET 1: 733 CONCORD AVENUE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Wave Life Sciences Ltd.
CENTRAL INDEX KEY: 0001631574
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: U0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 CROSS STREET
STREET 2: #10-00
CITY: SINGAPORE
STATE: U0
ZIP: 048424
BUSINESS PHONE: 617-206-4830
MAIL ADDRESS:
STREET 1: 8 CROSS STREET
STREET 2: #10-00
CITY: SINGAPORE
STATE: U0
ZIP: 048424
FORMER COMPANY:
FORMER CONFORMED NAME: WAVE Life Sciences Ltd.
DATE OF NAME CHANGE: 20170516
FORMER COMPANY:
FORMER CONFORMED NAME: Wave Life Sciences Ltd.
DATE OF NAME CHANGE: 20151106
FORMER COMPANY:
FORMER CONFORMED NAME: Wave Life Sciences LTD.
DATE OF NAME CHANGE: 20151106
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-23
0
0001631574
Wave Life Sciences Ltd.
WVE
0001679039
Panzara Michael A.
C/O WAVE LIFE SCIENCES LTD.,
733 CONCORD AVE.
CAMBRIDGE
MA
02138
0
1
0
0
Franchise Lead, Neurology
Ordinary Shares
2018-01-23
4
A
0
17500
0.00
A
39736
D
Share Option (right to buy)
40.05
2018-01-23
4
A
0
35000
0.00
A
2028-01-23
Ordinary Shares
35000
35000
D
Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 15, 2019, through February 15, 2022.
The option vests as to 25% of the shares on February 15, 2019 and vests as to an additional 6.25% of the shares quarterly thereafter until February 15, 2022.
/s/ Michael A. Panzara
2018-01-25